Search Results - "Bortolus, G."

PO-0758: Adjuvant or Salvage?10-y results of the AIRO Group on Prostate cancer multicentre prospective trial by Maurizi, F, Antognoni, P, Barra, S, Bertoni, F, Bonetta, A, Bortolus, G, Colombo, A, Frezza, G, Gabriele, O, Iotti, C, Mattana, F, Meregalli, S, Moro, G, Signor, M, Malinverni, G

Get full text

1595P Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience by Buriolla, S., Pravisano, F., Costa, J., Alberti, M., Bortolus, G., Zapelloni, G., De Pieri, G., Targato, G., Pascoletti, G., Puglisi, F., Fasola, G., Minisini, A.M.M.

Get full text

2119P The prognostic impact of nutritional assessment and scores in advanced gastric cancer by Torresan, S., De Scordilli, M., Bortolus, G., Bortolot, M., Zapelloni, G., Mazzeo, R., Totaro, F., De Pieri, G., Zanchetta, C., Michelotti, A., Casagrande, M., Fanotto, V., Garattini, S.K., Cardellino, G.G., Pella, N., Iacono, D., Puglisi, F., Fasola, G.

Get full text

P198 Applying TDM and PGx in mRCC patients treated with Sunitinib to customize drug dosing by Bortolus, G., Cecchin, E., Gagno, S., Posocco, B., Toffoli, G., Santarossa, S., Spina, M., Fratino, L., Puglisi, F.

Get full text

95P Implementation of TDM and PGx in mRCC patients treated with sunitinib to personalize drug dosing by Bortolus, G., Cecchin, E., Gagno, S., Posocco, B., Toffoli, G., Santarossa, S., Spina, M., Fratino, L., Puglisi, F.

Get full text